Grifols
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Grifols and buy or sell other stocks, ETFs, and their options commission-free!About GRFS
Grifols SA is a global specialty plasma therapeutics company that engages in the development, manufacturing, and distribution of a broad range of biological medicines based on plasma-derived proteins. It operates through the following segments: Biopharma, Diagnostic, Bio Supplies, and Others.
CEOJose Ignacio Abia Buenache
CEOJose Ignacio Abia Buenache
Employees25,258
Employees25,258
HeadquartersBarcelona, Catalonia
HeadquartersBarcelona, Catalonia
Founded1909
Founded1909
Employees25,258
Employees25,258
GRFS Key Statistics
Market cap7.07B
Market cap7.07B
Price-Earnings ratio10.23
Price-Earnings ratio10.23
Dividend yield2.88%
Dividend yield2.88%
Average volume384.87K
Average volume384.87K
High today$8.00
High today$8.00
Low today$7.86
Low today$7.86
Open price$7.92
Open price$7.92
Volume114.57K
Volume114.57K
52 Week high$10.84
52 Week high$10.84
52 Week low$6.96
52 Week low$6.96
GRFS News
New York Times 18h
After 2 Plasma Donor Deaths, Company Pauses Clinics in Canada - The New York Times...
TipRanks 4d
Grifols completes clinical portion of SPARTA trialGrifols (GRFS) announced the completion of the clinical portion of SPARTA, its phase 3 outcomes study evaluating the clinical efficacy and safety of two dose re...
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.